Institut de Cancérologie de Bourgogne
- Research works
- 80 ▲ 33% vs 2013–17
- Citations
- 513 6.4 per fractional work
- Top-10% rate
- 8.9% record average 16.5%
- Open access
- 38% world 28%
Not ranked overall: Institut de Cancérologie de Bourgogne is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 5.2×. Every wedge is a field page.
- Health Professions 5.2×
- Medicine 2.9×
- Immunology and Microbiology 2.2×
- Nursing 1.9×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Arts and Humanities 1.4×
- Business, Management and Accounting 1.0×
- Decision Sciences 0.9×
- Physics and Astronomy 0.7×
- Agricultural and Biological Sciences 0.5×
- Psychology 0.4×
- Mathematics 0.2×
- Chemistry 0.2×
- Social Sciences 0.2×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Computer Science 0.2×
- Neuroscience 0.1×
- Economics, Econometrics and Finance 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
Which keywords describe research at Institut de Cancérologie de Bourgogne?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Primary Care, Prostate Cancer, Public Health, Palliative Care, Neoadjuvant Therapy and Healthcare Policy.
- Quality of Life
- Patient Rights
- Inequalities
- Healthcare Legislation
- Prostate Cancer
- Public Health
- Immunotherapy
- Epidemiology
- Chemotherapy
- Primary Care
- Palliative Care
- Healthcare Policy
- Neoadjuvant Therapy
- Genetic Mutations
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Epidemiology2▲ 2.3×14 topics
- Immunotherapy2▲ 12×8 topics
- Chemotherapy2▲ 11×14 topics
- Public Health2▲ 5.0×4 topics
- Primary Care1▲ 19×3 topics
- Prostate Cancer1▲ 49×2 topics
- Palliative Care1▲ 37×2 topics
- Healthcare Legislation1▲ 89×1 topic
- Healthcare Policy1▲ 58×1 topic
- Inequalities1▲ 156×1 topic
- Neoadjuvant Therapy1▲ 24×5 topics
- Patient Rights1▲ 72×1 topic
- Genetic Mutations1▲ 12×5 topics
- Quality of Life1▲ 3.5×8 topics
Which research topics does Institut de Cancérologie de Bourgogne publish most on?
By volume in 2022–2025: Healthcare Systems and Practices, Health, Medicine and Society, Prostate Cancer Treatment and Research and Prostate Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Healthcare Systems and Practices General Health Professions 1 works
- 2 Health, Medicine and Society General Health Professions 1 works
- 3 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 4 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 5 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 6 Historical Linguistics and Language Studies Language and Linguistics 0 works
- 7 Vibrio bacteria research studies Endocrinology 0 works
- 8 Colorectal and Anal Carcinomas Surgery 0 works
- 9 Urinary Tract Infections Management Epidemiology 0 works
- 10 Culinary Culture and Tourism Food Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut de Cancérologie de Bourgogne's research output changed?
Output in 2018–2022 was 33% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.